USPTO serial 79361574
AKRIBION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 14, 2024
- Examiner
- LAVACHE, LINDA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AKRIBION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Recycling of waste and trash; air purification and treatment of water; food and drink preservation; processing of biological materials, namely, batch biological treatment services; waste treatment; joining of materials or substances, namely, custom additive manufacturing for others; treatment of hazardous substances, namely, waste, gases and liquids; treatment of materials using biotechnological method, namely, bio-hazard biological decontamination services | ACTIVE | — |
| 042 | Testing of materials; quality control for others; biological analysis; biological research; biological laboratory services; biological research and analysis; biological research; clinical research in the field of pharmaceuticals and medical research; research services, namely, scientific research; provision of research services, namely, product research; biomedical research services; industrial research in the field of pharmaceuticals; medical research; pharmaceutical research services; genetic research; research relating to biotechnology; providing information relating to scientific research in the fields of biochemistry and biotechnology; scientific research; technical research, namely, biochemistry research services, biotechnology research services, Research in the field of DNA repair technology, RNA interference technology research, Research in the field of gene editing technology ; chemical research and analysis services; medical, biopharmaceutical and biotechnological research laboratories; research and development of new products for others; computer aided scientific research services; computer aided industrial research services in the field of pharmaceuticals, biotechnology and medicine; biochemical research and analysis; scientific research relating to biology; biotechnological research; biotechnological research relating to industry; scientific and industrial research in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; scientific research for medical purposes; industrial analysis and research services in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; medical and pharmacological research services; biological research laboratory services; chemical research laboratory services; chemical research; pharmaceutical research and development; DNA screening for scientific research purposes; research to develop new products; research in the field of gene therapy; cell separation research services; biochemical research and development; research in the field of science provided by engineers; research and development services in the field of chemistry; scientific services, namely scientific investigations for medical and pharmaceutical purposes and medical research relating thereto; scientific research relating to genetics; research and development in the pharmaceutical and biotechnology fields; preparation of biological samples for analysis in research laboratories; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; consultancy in the field of industrial research relating to pharmaceuticals; consultancy in the field of scientific research; analysis of human tissues for medical research; preparation of biological samples for testing and analysis in research laboratories; research and development in the field of microorganisms and cells; biochemical analysis; scientific analysis in the field of biochemistry and biotechnology; technological analysis services, namely technological analysis of gene editing technology, RNA interference technology, DNA repair technology; chemical analysis; scientific research and analysis in the field of biochemistry; analysis in the field of molecular biology; scientific research in the field of genetics; genetic engineering; molecular biology research; scientific research in the field of DNA modification; industrial research in the field of DNA modification ; pharmaceutical research in the field of DNA modification; veterinary research in the field of DNA modification; medical research in the field of DNA modification; veterinary pharmaceutical research in the field of DNA modification; biological testing of materials; biochemical engineering services; biotechnological research relating to agriculture; biotechnological research relating to livestock; analysis services relating to the testing of chemical ingredients in liquids; analysis services relating to the determination of bacterial content in liquids; analysis services relating to the detection of bacterial content in liquids; bacteriological analysis; bacteriological research and analysis; bacteriological research and testing; advice on research in the field of pharmacogenetics; advice on pharmaceutical research and development; consultancy in the field of bacteriological research; consultancy services relating to technological research of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; consultancy services relating to scientific research; biochemical analysis; biochemical research service; biotechnical research in the industrial sector, namely, biotechnical research in the field of pharmaceuticals; computer-aided industrial analysis services in the field of pharmaceuticals; computer-aided scientific analysis in the field of pharmaceuticals; medical research laboratory services; medical laboratory services; DNA verification for scientific research purposes; conducting chemical research; research in the field of biotechnology; research in the field of medicine; research in the medical field; research on biotechnology; research on chemistry; research and development in the field of bacteriology; research and testing in the fields of bacteriology and virology; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; research and development services in the field of microorganisms and cells; research work of engineers in the technological field, namely, research in the field of genetic engineering; scientific research work by engineers; research for the development of new products; medical research services; pharmaceutical research; pharmaceutical development; technical research services, namely, product research; scientific services, namely, scientific laboratory services and related scientific research; scientific research in the field of bacteriology; scientific research in the field of pharmacy; scientific research in biology; scientific research in the field of genetics and genetic engineering; scientific research and development of new products for others; scientific research using databases; scientific research services; scientific and technological services, namely, scientific laboratory and software development in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; research and design of new products in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; industrial analysis and research services in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; design and development of computer software for use in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; consultancy and information in relation to the aforesaid services | ACTIVE | — |
| 044 | Medical services based on biotechnological methods; veterinary services based on biotechnological methods; hygienic and beauty care for human beings and animals based on biotechnological methods; agriculture, horticulture and forestry services, namely, cultivation of agricultural plants for others, horticultural services, and forest habitat restoration, all based on biotechnological methods; regenerative medicine services; medical analysis services for diagnostic and treatment purposes by medical laboratories; medical treatment with cultured cells; medical screening; animal breeding; DNA screening for medical purposes; conducting medical analysis by a medical laboratory for the purpose of the treatment of persons; health care for people; medical analysis services relating to the treatment of persons; medical analysis for the diagnosis and treatment of persons; medical diagnostic testing and analysis services; medical services; medical services in the field of diabetes; medical and health care services; medical and health care services relating to DNA, genetics and genetic testing; medical services for the treatment of the skin; medical services for the treatment of diseases of the human body; medical care and analysis services relating to the treatment of patients; providing information relating to medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Akribion Therapeutics GmbH
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AKRIBION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 8, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 8, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 4, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 4, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 4, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 14, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 14, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 14, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 27, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 20, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 20, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 20, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 13, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 13, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 13, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 13, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |